Loading...
An overview of antibody–drug conjugates in oncological practice
Antibody–drug conjugates (ADCs) are designed to manipulate the toxic efficacy of specific chemotherapeutic compounds, employing the high affinity of antibody-mediated delivery so as to drive them selectively to target cancer cells. These immunoconjugates encompass the general tendency towards precis...
Saved in:
| Published in: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543133/ https://ncbi.nlm.nih.gov/pubmed/33088347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920962997 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|